UBS O'Connor’s SC Health Corporation SCPE Stock Holding History

UBS O'Connor’s Portfolio SCPE Stock Details SCPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-194,648	Closed	-$1.96M	–	1058
2021 Q2	$1.96M	Sell	194,648 -305,334	-61%	-$3.08M	0.02%	489
2021 Q1	$5.04M	Buy	499,982 +43,734	+10%	+$451K	0.07%	188
2020 Q4	$4.68M	Hold	456,248	–	–	0.1%	233
2020 Q3	$4.6M	Sell	456,248 -778,752	-63%	-$7.87M	0.12%	115
2020 Q2	$12.5M	Sell	1,235,000 -65,000	-5%	-$649K	0.28%	91
2020 Q1	$13.1M	Buy	1,300,000 +250,000	+24%	+$2.48M	0.27%	86
2019 Q4	$10.4M	Buy	1,050,000 +550,000	+110%	+$5.43M	0.3%	66
2019 Q3	$4.96M	Buy	+500,000	New	+$4.94M	0.14%	117

UBS O'Connor's SCPE Position: Q3 2021 in Review

UBS O'Connor sold out of SC Health Corporation (SCPE) in Q3 2021, closing a stake of 194,648 shares — an estimated $1.96M sold.

UBS O'Connor first reported a position in SCPE in Q3 2019 and held it in 8 quarters. The position peaked at $13.1M in Q1 2020. 0 funds tracked by Wall St. Rank hold SCPE as of Q3 2021.

UBS O'Connor reported no remaining SC Health Corporation position as of Q3 2021 after selling out during the quarter.
UBS O'Connor sold 194,648 SC Health Corporation shares in Q3 2021, an estimated $1.96M.
UBS O'Connor first reported a position in SC Health Corporation in Q3 2019 and held it in 8 quarters.
UBS O'Connor's SC Health Corporation position peaked at $13.1M in Q1 2020.
0 funds tracked by Wall St. Rank held SC Health Corporation as of Q3 2021.

Based on UBS O'Connor's 13F filing for Q3 2021, filed 12 Nov 2021.